Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBMI for Mercury Intoxication in Colombia
NCT04183595Phase 3Recruiting
- Sponsor
- EmeraMed
- Start
- Nov 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of emeramide in mercury poisoning, sponsored by EmeraMed. Started Nov 2023; status: recruiting.
02
Drugs
emeramide
03
Conditions
mercury poisoning
Beyond the preview
Go deeper on NCT04183595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04183595.